KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Shares Issued (2016 - 2025)

Repligen (RGEN) has disclosed Shares Issued for 16 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued fell 46.37% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.2 million, a 26.04% decrease, with the full-year FY2025 number at $3.2 million, down 26.04% from a year prior.
  • Shares Issued was $1.0 million for Q4 2025 at Repligen, up from $678000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.3 million in Q3 2022 to a low of -$75000.0 in Q3 2023.
  • A 5-year average of $849052.6 and a median of $843000.0 in 2024 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: plummeted 103.23% in 2023, then soared 3158.62% in 2024.
  • Repligen's Shares Issued stood at $1.9 million in 2021, then plummeted by 51.11% to $923000.0 in 2022, then rose by 17.98% to $1.1 million in 2023, then skyrocketed by 77.04% to $1.9 million in 2024, then crashed by 46.37% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Shares Issued are $1.0 million (Q4 2025), $678000.0 (Q3 2025), and $1.5 million (Q1 2025).